Linda Thorén

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BREAST CANCER RESEARCH AND TREATMENT. 2023;198(3):499-508

Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records.

Thorén L; Margolin S; Eliasson E; Bergh J; Lindh JD
Article: BREAST CANCER RESEARCH AND TREATMENT. 2021;190(3):451-462

Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.

Thorén L; Eriksson M; Lindh JD; Czene K; Bergh J; Eliasson E; Hall P; Margolin S
Article: ANNALS OF ONCOLOGY. 2021;32(10):1286-1293

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.

He W; Eriksson M; Eliasson E; Grassmann F; Bäcklund M; Gabrielson M; Hammarström M; Margolin S; Thorén L; Wengström Y; Borgquist S; Hall P; Czene K
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(17):1899-1908

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.

Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lång K; Tapia J; Bäcklund M; Discacciati A; Crippa A; Gabrielson M; Hammarström M; Wengström Y; Czene K; Hall P
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021;87(3):1243-1252

Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles.

Thorén L; Lindh JD; Ackehed G; Kringen MK; Hall P; Bergh J; Molden E; Margolin S; Eliasson E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6):548-557

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer.

He W; Grassmann F; Eriksson M; Eliasson E; Margolin S; Thorén L; Hall P; Czene K
Article: PHARMACOGENOMICS. 2013;14(6):613-622

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients.

Margolin S; Lindh JD; Thorén L; Xie H; Koukel L; Dahl M-L; Eliasson E

Alla övriga publikationer

Thesis / dissertation: 2023

CYP2D6-polymorphism and effect of adjuvant tamoxifen in breast cancer patients

Thorén, Linda

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk forskning o utbildning, Södersjukhuset, Karolinska Institutet, 2024

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI